Abstract
AstraZeneca has rolled out a global Temperature Monitoring Program. The presentation will focus on the reasons for having taken that approach, the various challenges we met ,and also some learning points and recent changes in our program.
AstraZeneca believes that it is a good ethic to keep control of the products during transportation between the AstraZeneca sites; it also gives us information on the transport routes and allows us to continually improve our transports. Even though cool chain transports are challenging, we found room temperature transports even more challenging mostly due to complexity between markets and product submissions. It’s key to be pragmatic, keep it simple, have clear roles and responsibilities and have the same information at hand.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Axelsson, C. (2010). Temperature Monitoring During Shipment and Storage. In: Huynh-Ba, K. (eds) Pharmaceutical Stability Testing to Support Global Markets. Biotechnology: Pharmaceutical Aspects, vol XII. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0889-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0889-6_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0888-9
Online ISBN: 978-1-4419-0889-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)